Rabies vaccine
Rabies vaccine guidance for post-exposure prevention, with IM and intradermal schedules based on vaccination status.
Indications
Prevention of rabies after category II and III exposures.
Composition, forms, route of administration
- Inactivated virus vaccine prepared from cell cultures (CCEEV), in embryonated egg or purified cells such as chick embryo-cells, Vero-cells, or human diploid-cells.
- Powder for injection in monodose vial, to be dissolved with the entire vial of the diluent, 0.5 ml or 1 ml depending on the manufacturer.
- IM route: do not administer into the gluteal muscle. Child under 2 years: inject into the anterolateral part of the thigh. Child 2 years and over and adult: inject into the deltoid muscle.
- ID route: child and adult, inject into the deltoid muscle, the anterolateral part of the thigh, or the suprascapular region.
- Child and adult: one IM dose equals 0.5 or 1 ml depending on the vaccine used; one ID dose equals 0.1 ml regardless of vaccine used.
Dose and vaccination schedule
The simplest vaccination schedules endorsed by the WHO are the following.
Vaccination schedules may vary from country to country. The schedule depends on the patient's vaccination status at the moment of exposure and the route of administration used. Follow manufacturer's instructions.
The first dose should be administered as soon as possible after exposure, even if the patient seeks care long after exposure. The patient must receive all recommended doses.
If a vaccine dose is delayed or the route of administration is changed, continue according to the chosen route and do not recommence the schedule.
No rabies vaccination, incomplete vaccination, complete vaccination with an NTV, or unknown vaccination status
- IM route: D0, 2 doses (1 dose in each arm or thigh) plus a single dose of rabies immunoglobulin into the wound in the event of category III exposure on D0. D7, 1 dose. D21, 1 dose.
- Alternative IM route uses the 4-dose Essen regimen over 14 to 28 days or the Zagreb regimen over 21 days.
- ID route: D0, 1 dose plus rabies immunoglobulin in the event of category III exposure. D3, 2 doses (1 dose in each arm). D7, 1 dose. D14, 1 dose, with the last injection between D14 and D28 if needed.
- Another possible ID schedule: 4 ID doses on D0, 1 dose in each arm and 1 dose in each thigh.
Complete vaccination with a CCEEV
- IM or ID route: D0, 1 dose. D3, 1 dose. D7, 2 doses (1 dose in each arm).
Immunocompromised patient
- 1 dose on D0, D7, and between D21 and D28 by IM or ID route, as well as a single dose of rabies immunoglobulin.
Contra-indications, adverse effects, precautions
- Do not administer corticoids concomitantly because vaccine efficacy is diminished.
- May cause benign local reactions at the injection site such as pain and induration, fever, malaise, headache, fatigue, gastrointestinal disturbances, and rarely anaphylactic reaction.
- Ensure that the vaccine does not enter a blood vessel. Aspirate prior to injection to confirm that the needle is not in a vein.
- Intradermal vaccination: incorrect ID technique results in treatment failure. If correct technique cannot be assured, use IM route.
- If administered simultaneously with rabies immunoglobulin and other vaccines, use different syringes and injection sites.
- Pregnancy and breast-feeding: no contra-indication.
- Rabies vaccine is also used for pre-exposure vaccination in persons at high risk of infection.
- Avoid the use of vaccines prepared from animal nerve tissue because they are less immunogenic and more likely to cause severe adverse effects.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.
